Bioresorbable Drug-Eluting Stents Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194414 | Category: Medical Devices & Consumables | Pages: 75 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Bioresorbable Drug-Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioresorbable Drug-Eluting Stents. This report contains market size and forecasts of Bioresorbable Drug-Eluting Stents in global, including the following market information:
Global Bioresorbable Drug-Eluting Stents Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bioresorbable Drug-Eluting Stents Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Bioresorbable Drug-Eluting Stents companies in 2022 (%)
The global Bioresorbable Drug-Eluting Stents market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Metal Based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bioresorbable Drug-Eluting Stents include Medtronic, Abbott, Johnson & Johnson, Bostonscientific, B. Braun Melsungen AG, Lepu Medical, Microport, JW Medical and Lifetech Scientific, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioresorbable Drug-Eluting Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioresorbable Drug-Eluting Stents Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bioresorbable Drug-Eluting Stents Market Segment Percentages, by Type, 2022 (%)
    Metal Based
    Polymer
Global Bioresorbable Drug-Eluting Stents Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bioresorbable Drug-Eluting Stents Market Segment Percentages, by Application, 2022 (%)
    Under 50 Years Old
    Abover 50 Years Old
Global Bioresorbable Drug-Eluting Stents Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bioresorbable Drug-Eluting Stents Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bioresorbable Drug-Eluting Stents revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bioresorbable Drug-Eluting Stents revenues share in global market, 2022 (%)
Key companies Bioresorbable Drug-Eluting Stents sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Bioresorbable Drug-Eluting Stents sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Medtronic
    Abbott
    Johnson & Johnson
    Bostonscientific
    B. Braun Melsungen AG
    Lepu Medical
    Microport
    JW Medical
    Lifetech Scientific
    Yinyi Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bioresorbable Drug-Eluting Stents, market overview.
Chapter 2: Global Bioresorbable Drug-Eluting Stents market size in revenue and volume.
Chapter 3: Detailed analysis of Bioresorbable Drug-Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bioresorbable Drug-Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bioresorbable Drug-Eluting Stents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Bioresorbable Drug-Eluting Stents Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Bioresorbable Drug-Eluting Stents Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Bioresorbable Drug-Eluting Stents Overall Market Size
    2.1 Global Bioresorbable Drug-Eluting Stents Market Size: 2022 VS 2029
    2.2 Global Bioresorbable Drug-Eluting Stents Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Bioresorbable Drug-Eluting Stents Sales: 2018-2029
3 Company Landscape
    3.1 Top Bioresorbable Drug-Eluting Stents Players in Global Market
    3.2 Top Global Bioresorbable Drug-Eluting Stents Companies Ranked by Revenue
    3.3 Global Bioresorbable Drug-Eluting Stents Revenue by Companies
    3.4 Global Bioresorbable Drug-Eluting Stents Sales by Companies
    3.5 Global Bioresorbable Drug-Eluting Stents Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Bioresorbable Drug-Eluting Stents Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Bioresorbable Drug-Eluting Stents Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Bioresorbable Drug-Eluting Stents Players in Global Market
        3.8.1 List of Global Tier 1 Bioresorbable Drug-Eluting Stents Companies
        3.8.2 List of Global Tier 2 and Tier 3 Bioresorbable Drug-Eluting Stents Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Bioresorbable Drug-Eluting Stents Market Size Markets, 2022 & 2029
        4.1.2 Metal Based
        4.1.3 Polymer
    4.2 By Type - Global Bioresorbable Drug-Eluting Stents Revenue & Forecasts
        4.2.1 By Type - Global Bioresorbable Drug-Eluting Stents Revenue, 2018-2023
        4.2.2 By Type - Global Bioresorbable Drug-Eluting Stents Revenue, 2024-2029
        4.2.3 By Type - Global Bioresorbable Drug-Eluting Stents Revenue Market Share, 2018-2029
    4.3 By Type - Global Bioresorbable Drug-Eluting Stents Sales & Forecasts
        4.3.1 By Type - Global Bioresorbable Drug-Eluting Stents Sales, 2018-2023
        4.3.2 By Type - Global Bioresorbable Drug-Eluting Stents Sales, 2024-2029
        4.3.3 By Type - Global Bioresorbable Drug-Eluting Stents Sales Market Share, 2018-2029
    4.4 By Type - Global Bioresorbable Drug-Eluting Stents Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Bioresorbable Drug-Eluting Stents Market Size, 2022 & 2029
        5.1.2 Under 50 Years Old
        5.1.3 Abover 50 Years Old
    5.2 By Application - Global Bioresorbable Drug-Eluting Stents Revenue & Forecasts
        5.2.1 By Application - Global Bioresorbable Drug-Eluting Stents Revenue, 2018-2023
        5.2.2 By Application - Global Bioresorbable Drug-Eluting Stents Revenue, 2024-2029
        5.2.3 By Application - Global Bioresorbable Drug-Eluting Stents Revenue Market Share, 2018-2029
    5.3 By Application - Global Bioresorbable Drug-Eluting Stents Sales & Forecasts
        5.3.1 By Application - Global Bioresorbable Drug-Eluting Stents Sales, 2018-2023
        5.3.2 By Application - Global Bioresorbable Drug-Eluting Stents Sales, 2024-2029
        5.3.3 By Application - Global Bioresorbable Drug-Eluting Stents Sales Market Share, 2018-2029
    5.4 By Application - Global Bioresorbable Drug-Eluting Stents Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Bioresorbable Drug-Eluting Stents Market Size, 2022 & 2029
    6.2 By Region - Global Bioresorbable Drug-Eluting Stents Revenue & Forecasts
        6.2.1 By Region - Global Bioresorbable Drug-Eluting Stents Revenue, 2018-2023
        6.2.2 By Region - Global Bioresorbable Drug-Eluting Stents Revenue, 2024-2029
        6.2.3 By Region - Global Bioresorbable Drug-Eluting Stents Revenue Market Share, 2018-2029
    6.3 By Region - Global Bioresorbable Drug-Eluting Stents Sales & Forecasts
        6.3.1 By Region - Global Bioresorbable Drug-Eluting Stents Sales, 2018-2023
        6.3.2 By Region - Global Bioresorbable Drug-Eluting Stents Sales, 2024-2029
        6.3.3 By Region - Global Bioresorbable Drug-Eluting Stents Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Bioresorbable Drug-Eluting Stents Revenue, 2018-2029
        6.4.2 By Country - North America Bioresorbable Drug-Eluting Stents Sales, 2018-2029
        6.4.3 US Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.4.4 Canada Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.4.5 Mexico Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Bioresorbable Drug-Eluting Stents Revenue, 2018-2029
        6.5.2 By Country - Europe Bioresorbable Drug-Eluting Stents Sales, 2018-2029
        6.5.3 Germany Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.5.4 France Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.5.5 U.K. Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.5.6 Italy Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.5.7 Russia Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.5.8 Nordic Countries Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.5.9 Benelux Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Bioresorbable Drug-Eluting Stents Revenue, 2018-2029
        6.6.2 By Region - Asia Bioresorbable Drug-Eluting Stents Sales, 2018-2029
        6.6.3 China Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.6.4 Japan Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.6.5 South Korea Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.6.6 Southeast Asia Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.6.7 India Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Bioresorbable Drug-Eluting Stents Revenue, 2018-2029
        6.7.2 By Country - South America Bioresorbable Drug-Eluting Stents Sales, 2018-2029
        6.7.3 Brazil Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.7.4 Argentina Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Bioresorbable Drug-Eluting Stents Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Bioresorbable Drug-Eluting Stents Sales, 2018-2029
        6.8.3 Turkey Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.8.4 Israel Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.8.5 Saudi Arabia Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
        6.8.6 UAE Bioresorbable Drug-Eluting Stents Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Medtronic
        7.1.1 Medtronic Company Summary
        7.1.2 Medtronic Business Overview
        7.1.3 Medtronic Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.1.4 Medtronic Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.1.5 Medtronic Key News & Latest Developments
    7.2 Abbott
        7.2.1 Abbott Company Summary
        7.2.2 Abbott Business Overview
        7.2.3 Abbott Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.2.4 Abbott Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.2.5 Abbott Key News & Latest Developments
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Company Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.3.4 Johnson & Johnson Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.3.5 Johnson & Johnson Key News & Latest Developments
    7.4 Bostonscientific
        7.4.1 Bostonscientific Company Summary
        7.4.2 Bostonscientific Business Overview
        7.4.3 Bostonscientific Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.4.4 Bostonscientific Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.4.5 Bostonscientific Key News & Latest Developments
    7.5 B. Braun Melsungen AG
        7.5.1 B. Braun Melsungen AG Company Summary
        7.5.2 B. Braun Melsungen AG Business Overview
        7.5.3 B. Braun Melsungen AG Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.5.4 B. Braun Melsungen AG Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.5.5 B. Braun Melsungen AG Key News & Latest Developments
    7.6 Lepu Medical
        7.6.1 Lepu Medical Company Summary
        7.6.2 Lepu Medical Business Overview
        7.6.3 Lepu Medical Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.6.4 Lepu Medical Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.6.5 Lepu Medical Key News & Latest Developments
    7.7 Microport
        7.7.1 Microport Company Summary
        7.7.2 Microport Business Overview
        7.7.3 Microport Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.7.4 Microport Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.7.5 Microport Key News & Latest Developments
    7.8 JW Medical
        7.8.1 JW Medical Company Summary
        7.8.2 JW Medical Business Overview
        7.8.3 JW Medical Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.8.4 JW Medical Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.8.5 JW Medical Key News & Latest Developments
    7.9 Lifetech Scientific
        7.9.1 Lifetech Scientific Company Summary
        7.9.2 Lifetech Scientific Business Overview
        7.9.3 Lifetech Scientific Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.9.4 Lifetech Scientific Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.9.5 Lifetech Scientific Key News & Latest Developments
    7.10 Yinyi Biotech
        7.10.1 Yinyi Biotech Company Summary
        7.10.2 Yinyi Biotech Business Overview
        7.10.3 Yinyi Biotech Bioresorbable Drug-Eluting Stents Major Product Offerings
        7.10.4 Yinyi Biotech Bioresorbable Drug-Eluting Stents Sales and Revenue in Global (2018-2023)
        7.10.5 Yinyi Biotech Key News & Latest Developments
8 Global Bioresorbable Drug-Eluting Stents Production Capacity, Analysis
    8.1 Global Bioresorbable Drug-Eluting Stents Production Capacity, 2018-2029
    8.2 Bioresorbable Drug-Eluting Stents Production Capacity of Key Manufacturers in Global Market
    8.3 Global Bioresorbable Drug-Eluting Stents Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Bioresorbable Drug-Eluting Stents Supply Chain Analysis
    10.1 Bioresorbable Drug-Eluting Stents Industry Value Chain
    10.2 Bioresorbable Drug-Eluting Stents Upstream Market
    10.3 Bioresorbable Drug-Eluting Stents Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Bioresorbable Drug-Eluting Stents Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Bioresorbable Drug-Eluting Stents Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?